Vector Science & Therapeutics Builds 15-Patent-Application Intellectual Property Portfolio Around Precision Therapeutic Delivery, Anchored by Peptide and Biologic Administration Technologies

Summary

Vector Science & Therapeutics announced the expansion of its intellectual property portfolio with 15 pending patent applications focused on precision therapeutic delivery technologies, including peptide and biologic administration, drug delivery, pain management, oncology, regenerative medicine, and wound care applications.